Development of monoclonal antibodies specific for human glandular kallikrein (hK2): Development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity

Urology

Volumn 51, Issue 5, 1998, Pages 804-809

  Finlay, Judith A ^a   Evans, Cindy L ^a   Day, John R ^a   Payne, Janice K ^a   Mikolajczyk, Stephen D ^a   Millar, Lisa S ^a   Kuus Reichel, Kristine ^a   Wolfert, Robert L ^a   Rittenhouse, Harry G ^a  

^a Hybritech Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; TISSUE KALLIKREIN; TUMOR MARKER;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOASSAY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE;

ALPHA 1-ANTICHYMOTRYPSIN; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOASSAY; KALLIKREINS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC DISEASES; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SEMEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0031775549     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00107-1     Document Type: Article

References (26)

1. Malm J, Lilja H. Biochemistry of prostate specific antigen, PSA. Scand J Clin Lab Invest. 221:(suppl):1995;15-22.
2. McCormack RT, Rittenhouse HG, Finlay JA, Sokoloff RL, Wang TJ, Wolfert RL, Lilja H, Oesterling JE. Molecular forms of prostate-specific antigen and the human kallikrein gene family a new era . Urology. 45:1995;729-744.
3. Peehl DM. Prostate specific antigen role and function. Cancer. 75:1995;2021-2026.
4. Lilja H. Structure, function, and regulation of the enzyme activity of prostate-specific antigen. World J Urol. 11:1993;188-191.
5. Clements JA. The human kallikrein gene family a diversity of expression and function . Mol Cell Endocrinol. 99:1994;C1-C6.
6. Henttu P, Vihko P. Prostate-specific antigen and human glandular kallikrein two kallikreins of the human prostate . Ann Med. 26:1994;157-164.
7. Darson MF, Pacelli A, Roche PC, Rittenhouse HG, Wolfert RL, Young CYF, Klee GG, Tindall DJ, Bostwick DG. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma a novel prostate cancer marker . Urology. 49:1997;857-862.
8. Mikolajczyk SD, Millar LS, Kumar A, Saedi MS. Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors. Prostate. 34:1998;44-50.
9. Mikolajczyk SD, Millar LS, Marker KM, Grauer LS, Goel AS, Cass MMJ, Kumar A, Saedi MS. Ala 217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2. Eur J Biochem. 246:1997;440-446.
10. Kumar A, Goel AS, Hill TM, Mikolajczyk SD, Millar LS, Kuus-Reichel K, Saedi MS. Expression of human glandular kallikrein, hK2, in mammalian cells. Cancer Res. 56:1996;5397-5402.
11. Graves HC, Kamarei M, Stamey TA. Identity of prostate specific antigen and the semen protein P30 purified by a rapid chromatography technique. J Urol. 144:1990;1510-1515.
12. Sensabaugh GF, Blake ET. Seminal plasma protein p30 simplified purification and evidence for identity with prostate specific antigen . J Urol. 144:1990;1523-1526.
13. Knott C, Kuus-Reichel K, Liu RS, Wolfert RL. Development of antibodies for diagnostic assays. Price CP, Newman DJ. Principles and Practice of Immunoassay. 1997;37-64 Stockton, New York.
14. Rittenhouse HG, Wolfert RL, and Wang TJ: Editorial Comment to Corey E, Buhler KR, and Vessella RL: Cross-reactivity of ten anti-prostate specific antigen monoclonal antibodies with human glandular kallikrein. Urology 50: 567-572, 1997.
15. Catalona WJ, Richie JP, deKernion JB, Ahmann FR, Ratliff TL, Dalkin BL, Kavoussi LR, MacFarlane MT, Southwick PC. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer receiver operating characteristic curves . J Urol. 152:(6 Pt 1):1994;2031-2036.
16. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer results of a multicenter clinical trial of 6,630 men . J Urol. 151:1994;1283-1290.
17. Labrie F, Dupont A, Suburu R, Cusan L, Tremblay M, Gomez JL, Emond J. Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol. 147:(3 Pt 2):1992;846-851.
18. Wang TJ, Finlay JA, Mikolajczyk SD, Rittenhouse HG, Wolfert RL. Analysis of cross-reactivity of anti-PSA monoclonal antibodies with recombinant human glandular kallikrein (abstract). J Urol. 155:1996;695A.
19. Corey E, Buhler KR, Vessella RL. Cross-reactivity of ten anti-prostate specific antigen monoclonal antibodies with human glandular kallikrein. Urology. 50:1997;567-572.
20. Grauer LS, Finlay JA, Mikolajczyk SD, Pusateri KD, and Wolfert RL: Detection of human glandular kallikrein, hK2 as its precursor form and in complex with protease inhibitors in prostate carcinoma serum. J Androl 19: 1998 (in press).
21. Lilja H, Christensson A, Dahlen U, Matikainen MT, Nilsson O, Pettersson K, Lovgren T. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem. 37:1991;1618-1625.
22. Stenman U-H, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer assay of the complex improves clinical sensitivity for cancer . Cancer Res. 51:1991;222-226.
23. Catalona WJ. Clinical utility of measurements of free and total prostate-specific antigen (PSA) a review . Prostate. 7:(suppl):1996;64-69.
24. Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, Nadler RB. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA. 274:1995;1214-1220.
25. Charlesworth MC, Young CYF, Klee GG, Saedi MS, Mikolajczyk SD, Finlay JA, Tindall DJ. Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate specific antigen levels. Urology. 49:1997;487-493.
26. Piironen T, Lovgren J, Karp M, Eerola R, Lundwall A, Dowell B, Lovgren T, Lilja H, Pettersson K. Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum. Clin Chem. 42:1996;1034-1041.